Chanouzas, Dimitrios McGregor, Julie Nightingale, Peter Salama, Alan Szpirt, Wladimir Basu, Neil Morgan, Matthew Poulton, Caroline Draibe, Juliana Krarup, Elizabeth Dospinescu, Paula Dale, Jessica Pendergraft, William Lee, Keegan Egfjord, Martin Hogan, Susan Harper, Lorraine Additional file 1: of Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study Tables S1. Intravenous pulse methylprednisolone use and dosage. Table S2. Cyclophosphamide and oral prednisolone dose in intravenous pulse methylprednisolone (MP) and non-MP treated patients. Table S3. Factors associated with infection at 3 months on univariable and multivariable proportional hazards analysis. Figure S1. Time to infection by 3 months (A) and from 3 to 12 months (B) and time to severe infection by 3 months (C) and from 3 to 12 months (D) was examined by Kaplan-Meier curve analysis. Time to infection for patients that received MP is shown in the dashed line and that for non-MP treated patients in the solid line. (DOCX 150 kb) ANCA;Vasculitis;Methylprednisolone;Infection;Diabetes mellitus 2019-02-18
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Intravenous_pulse_methylprednisolone_for_induction_of_remission_in_severe_ANCA_associated_Vasculitis_a_multi-center_retrospective_cohort_study/7734242
10.6084/m9.figshare.7734242.v1